mirtogenol

used to treat intraocular hypertension

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Bombardelli, Ezio: 1 article (07/2008)
2.	Burki, Carolina: 1 article (07/2008)
3.	Gianni, Belcaro: 1 article (07/2008)
4.	Paolo, Morazzoni: 1 article (07/2008)
5.	Schönlau, Frank: 1 article (07/2008)
6.	Steigerwalt, Robert D: 1 article (07/2008)

1.	Glaucoma 07/10/2008 - "The results of this study indicate that Mirtogenol may represent a safe preventative intervention for lowering the risk for developing symptomatic glaucoma by controlling IOP and improving ocular blood flow." 07/01/2023 - "Thus, Mirtogenol supplementation is expected to be used to prevent glaucoma progression." 07/01/2023 - "The purpose of this research is to determine how Mirtogenol affects intraocular pressure (IOP) and retinal ganglion cells (RGCs) of apoptosis index in Wistar glaucoma models, as well as the relationship between IOP and RGC apoptosis index. " 07/01/2023 - "Effects of oral Mirtogenol on retinal ganglion cell apoptosis index and intraocular pressure in the Wistar glaucoma model."
2.	Hypertension (High Blood Pressure) 07/10/2008 - "Thirty-eight asymptomatic subjects with intraocular hypertension were either given Mirtogenol (20 subjects) or were not treated (18 subjects). " 07/10/2008 - "Effects of Mirtogenol on ocular blood flow and intraocular hypertension in asymptomatic subjects."